Ayurvedic Remedy Outperforms Pharmaceuticals in COVID-19 Comparative Clinical Trial

NEW DELHI / A clinical trial was conducted in India to monitor the outcome of combining natural treatment for COVID. An Ayurvedic Remedy called ‘Immunofree’ by Corival Life Sciences, and a supplement called ‘Reginmune’ by Biogetica are found to work better in a comparative clinical trial than Standard of Care.

From the start of the pandemic, medical professionals from across the world have been searching for a cure for Covid-19. China stopped corona by mandating the use of traditional Chinese medicine formulas for COVID-19. Madagascar and other countries took similar remedies, the mortality rate reported there under 1 per cent.

Half the participants in the clinical trial for ‘Immunforee’ & ‘Reginmune’ were given the 2 remedies, and the other half were given the government SOP(depending on patient condition and hospital norms, which included but not limited to Paracetamol (SOS) B-complex (OD) Vitamin-C (TID), Azithromycin (OD), Favipiravir and Pantocid (OD).

This herbal combination group had 88% of patients test negative on day 5, in comparison to SOP with only 72% negative on day 5. 100% of patients on Immunefree and Reginmune tested negative on day 10 and only 88% on SOP tested negative. Hence this study suggests that natural medicine from Ayurveda is outperforming pharmaceuticals currently being used. The groundbreaking results have been submitted to the Indian government in the hope that they will expedite the approval of Immunofree and Reginmune for COVID-19 treatment.

Dr. Vijaykumar Kamat, Medical Director, Biogetica said, “It seems to us that too much expectation and emphasis is being placed on a vaccine even though the virus is rapidly mutating. The flu vaccines have been around for 70 years and it hasn’t stopped the flu. Hence, one cannot expect corona to end with a vaccine alone. Safe and effective treatment is needed. This is essential because Immunofree hasn’t been repurposed for COVID. It was designed based on the multifaceted presentation of this particular virus and it addresses the virus with a unique patented 10 prong approach”.

Dr. Huzaifa Khorakiwala, CEO, Wockhardt Foundation said, “It is great to see natural medicine set a precedent like this. We will work closely with states of India and governments around the world to make Immunofree and Reginmune the gold standard in Coronavirus treatment.”

Apurve Mehra, Founder, Biogetica said, “Immunofree and Reginmune have now shown a result no medicine from any tradition has globally. With the entire world watching, we have shown how nature is essential in medicine for this virus. That nature has the answer when all else fails.”